Thyrocare Technologies Ltd. Conference Calls and Earnings Call Transcripts

Thyrocare Technologies Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter
All Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Thyrocare Technologies Ltd.
02 Aug 2022
1205.90
0.94%
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
We wish to inform you that as already intimated to you in our letter dated July 27, 2022, a conference call for the Indian and Overseas analysts / investors took place at 9.00 a.m. today, to discuss the Company's financial results for Quarter ended June 30, 2022. Mr. Rahul Guha, Managing Director & Chief Executive Officer and Mr. Sachin Salvi, Chief Financial Officer, represented the Management. We confirm that no Unpublished Price Sensitive Information was shared / discussed in the call. We are forwarding audio recording of the conference call. We have also uploaded it on our website. We will be forwarding the transcript shortly.
pdf
logo
Thyrocare Technologies Ltd.
02 Aug 2022
1205.90
0.94%
Results Earnings Call for Q1FY23 of Thyrocare Technologies
Conference Call with Thyrocare Technologies Management and Analysts on Q1FY23 Performance and Outlook. Listen to the full earnings transcript.
video
audio
 
logo
Thyrocare Technologies Ltd.
07 May 2022
1205.90
0.94%
pdf
logo
Thyrocare Technologies Ltd.
20 Feb 2021, 12:31PM
1205.90
0.94%
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith the transcript of the Earnings Call held on Thursday, February 04, 2021 at 05.00 P.M. local time, post declaration of the Company's unaudited financial results (Stand-alone and Consolidated) for Quarter / Nine Months ended December 31, 2020. This transcript is also made available at our website. Dr. A. Velumani, Chairman & Managing Director, Mr. Arindam Haldar, CEO, Mr. A. Sundararaju, CFO & Executive Director, Mr. Sachin Salvi, Vice-President- Finance, represented the Company.
pdf
logo
Thyrocare Technologies Ltd.
05 Feb 2021
1205.90
0.94%
Earnings Call for Q3FY21 of Thyrocare Technologies
Conference Call with Thyrocare Technologies Management and Analysts on Q3FY21 Performance and Outlook. Listen to the full earnings transcript.
video
 
logo
Thyrocare Technologies Ltd.
11 Jan 2021
1205.90
0.94%
Thyrocare Technologies Ltd - Business Update
BSE India
Intimation about (1) significant business revival in Q3 of the current financial year, after business activities resumed across all states, and the growth in the non-covid business and (2) increase in volume of RT-PCR tests making us most cost effective service provider to the patients.
pdf
logo
Thyrocare Technologies Ltd.
06 Nov 2020
1205.90
0.94%
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith the transcript of the Earnings Call held on Tuesday, November 03, 2020 at 12.00 Noon local time, post declaration of the Company's unaudited financial results (Stand-alone and Consolidated) for Quarter / Half Year ended September 30, 2020. This transcript is also made available at our website. Dr. A. Velumani, Chairman & Managing Director, Mr. Arindam Haldar, CEO, Mr. A. Sundararaju, CFO & Executive Director, Mr. Sachin Salvi, Vice-President- Finance, represented the Company.
pdf
logo
Thyrocare Technologies Ltd.
03 Nov 2020
1205.90
0.94%
Earnings Call for Q2FY21 of Thyrocare Technologies
Conference Call with Thyrocare Technologies Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.
video
 
logo
Thyrocare Technologies Ltd.
29 Jun 2019
1205.90
0.94%
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith a transcript of the conference call held on Tuesday, May 21, 2019 at 04.00 P.M. local time, to discuss the Company's Audited financial results (Stand-alone and Consolidated) for the year ended March 31, 2019. Dr. Velumani A., Ph.D., CEO, Mr. A. Sundararaju, CFO, Mr. Sachin Salvi, Vice-President- Finance and Dr. Caesar Sengupta, Vice-President- Operations, represented the Company.
pdf
logo
Thyrocare Technologies Ltd.
15 Nov 2018
1205.90
0.94%
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith a transcript of the conference call held on Monday, November 12, 2018 at 02.30 P.M. local time, to discuss the Company's unaudited financial results (Stand-alone and Consolidated) for Quarter / Half Year ended September 30, 2018....
pdf

Earnings Calls Podcast on